The role of thrombolytics in acute and chronic occlusion of the hand

Hand Clin. 2015 Feb;31(1):13-21. doi: 10.1016/j.hcl.2014.09.002. Epub 2014 Nov 25.

Abstract

Distal arm and hand ischemia from vessel thrombosis or embolism remains a difficult clinical challenge. The causes of ischemia are variable and include connective tissue disease, embolism, atherosclerosis, and iatrogenic etiology. Although reports are limited, treatment with catheter-directed thrombolysis has favorable results in cases of acute thrombosis, with most patients (80%) demonstrating improvement. Digital amputation rates are less than 10% and the hand is often salvaged. Bleeding and access-site complications remain prevalent in patients undergoing intra-arterial thrombolysis. This review discusses etiology, treatment approaches, outcomes, and complications when thrombolytic therapy is used for distal arm and hand ischemia.

Keywords: Arterial occlusion; Catheter; Hand ischemia; Thrombolysis; Thrombolytics.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Angiography
  • Chronic Disease
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Hand / blood supply*
  • Hand / diagnostic imaging
  • Humans
  • Ischemia / diagnostic imaging
  • Ischemia / drug therapy*
  • Thrombolytic Therapy
  • Thrombosis / drug therapy*
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator